MRTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 3.26%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $433,243.25

Mirati Therapeutics Insider Trading History Chart

Mirati Therapeutics Share Price & Price History

^$58.70

+0.30 (1.20%)

As of 01/23/2024 01:00 AM ET

This company will win the AI race

From Porter & Company | Ad

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.

Mirati Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/16/2024	Benjamin Hickey	EVP	Sell	1,597	$59.02	$94,254.94	117,028
1/8/2024	Benjamin Hickey	EVP	Sell	2,090	$58.92	$123,142.80	118,625
1/4/2024	Jamie Christensen	EVP	Sell	1,531	$58.81	$90,038.11	157,135
12/13/2023	Benjamin Hickey	EVP	Sell	2,220	$56.67	$125,807.40	103,694
9/8/2023	Jamie Christensen	EVP	Sell	2,388	$35.63	$85,084.44	144,032
8/11/2023	Boxer Capital, Llc	Insider	Buy	1,201,440	$27.80	$33,400,032.00	3,201,440
8/11/2023	Faheem Hasnain	Director	Buy	10,791	$27.80	$299,989.80	10,791
6/2/2023	Laurie Stelzer	CFO	Sell	4,647	$37.06	$172,217.82	80,015
5/24/2023	Jamie Christensen	EVP	Sell	619	$45.29	$28,034.51	124,123
1/18/2023	Julie M. Cherrington	Director	Sell	2,546	$44.66	$113,704.36
1/17/2023	David D Meek	CEO	Sell	3,179	$42.38	$134,726.02	61,792
1/17/2023	Jamie Christensen	EVP	Sell	2,245	$42.38	$95,143.10	97,878
1/9/2023	Benjamin Hickey	EVP	Sell	2,088	$45.37	$94,732.56	48,789
1/4/2023	Charles M. Baum	Insider	Sell	3,648	$46.60	$169,996.80	168,777
1/4/2023	Jamie Christensen	EVP	Sell	1,949	$46.60	$90,823.40	100,123
12/21/2022	Benjamin Hickey	EVP	Sell	3,248	$40.41	$131,251.68	50,877
12/21/2022	Charles M. Baum	Insider	Sell	9,092	$40.42	$367,498.64	172,425
12/21/2022	David D Meek	CEO	Sell	4,616	$40.41	$186,532.56	64,971
12/2/2022	Jamie Christensen	EVP	Sell	1,726	$90.19	$155,667.94	104,482
11/28/2022	Charles M. Baum	Insider	Sell	69,256	$100.00	$6,925,600.00	127,899
8/12/2022	Bruce L. A. Carter	Director	Sell	10,000	$85.49	$854,900.00	6,021
5/23/2022	Jamie Christensen	EVP	Sell	624	$63.54	$39,648.96	86,804
1/19/2022	Julie M. Cherrington	Director	Sell	1,475	$116.07	$171,203.25
1/18/2022	Charles M. Baum	Insider	Sell	2,517	$120.48	$303,248.16
1/18/2022	Jamie Christensen	EVP	Sell	627	$120.51	$75,559.77
1/18/2022	Vickie S. Reed	CAO	Sell	533	$120.48	$64,215.84
1/7/2022	Benjamin Hickey	EVP	Sell	1,964	$135.94	$266,986.16
1/7/2022	Vickie S. Reed	CAO	Sell	345	$135.94	$46,899.30
1/4/2022	Charles M. Baum	Insider	Sell	4,114	$147.75	$607,843.50
1/4/2022	Jamie Christensen	EVP	Sell	1,442	$147.72	$213,012.24
1/4/2022	Vickie S. Reed	CAO	Sell	758	$147.74	$111,986.92
12/6/2021	Jamie Christensen	EVP	Sell	1,201	$130.79	$157,078.79
12/3/2021	Charles M. Baum	Insider	Sell	47,204	$133.20	$6,287,572.80

Watch this before it gets removed

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Mirati Therapeutics (NASDAQ:MRTX)

Institutional Buying and Selling by Quarter

Mirati Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/11/2024	Vanguard Group Inc.	5,306,693	$311.77M	0.0%	-6.9%	7.565%
2/20/2024	Quarry LP	750	$44K	0.0%	-57.1%	0.001%
2/16/2024	Madison Avenue Partners LP	417,427	$24.52M	3.5%	N/A	0.595%
2/15/2024	Frazier Life Sciences Management L.P.	80,000	$4.70M	0.3%	N/A	0.114%
2/15/2024	Braslyn Ltd.	3,135,966	$184.24M	99.0%	N/A	4.470%
2/14/2024	ADAR1 Capital Management LLC	108,000	$6.35M	2.3%	N/A	0.154%
2/14/2024	PenderFund Capital Management Ltd.	6,570	$0.39M	0.0%	N/A	0.009%
2/14/2024	Avoro Capital Advisors LLC	4,886,840	$287.10M	4.0%	-26.7%	6.966%
2/14/2024	EHP Funds Inc.	25,000	$1.47M	0.5%	N/A	0.036%
2/14/2024	Water Island Capital LLC	343,735	$20.19M	2.1%	N/A	0.490%
2/14/2024	Sectoral Asset Management Inc.	6,474	$0.38M	0.2%	-96.4%	0.009%
2/13/2024	GABELLI & Co INVESTMENT ADVISERS INC.	219,513	$12.90M	2.4%	N/A	0.313%
2/13/2024	Gabelli Funds LLC	241,587	$14.19M	0.1%	N/A	0.344%
2/13/2024	Armistice Capital LLC	500,000	$29.38M	0.4%	-63.3%	0.713%
2/13/2024	Affinity Asset Advisors LLC	100,049	$5.88M	1.1%	+65.6%	0.143%
2/13/2024	Carmignac Gestion	27,804	$1.63M	0.0%	N/A	0.040%
2/13/2024	Rafferty Asset Management LLC	158,931	$9.34M	0.0%	-36.3%	0.227%
2/12/2024	Alberta Investment Management Corp	44,300	$2.60M	0.0%	N/A	0.063%
2/12/2024	Bank of Nova Scotia	72,000	$4.23M	0.0%	N/A	0.103%
2/12/2024	Treasurer of the State of North Carolina	24,258	$1.43M	0.0%	+21.0%	0.035%
2/12/2024	Hsbc Holdings PLC	783,092	$46.04M	0.0%	N/A	1.116%
2/9/2024	Franklin Resources Inc.	23,991	$1.41M	0.0%	-97.0%	0.034%
2/9/2024	Norges Bank	751,604	$44.16M	0.0%	N/A	1.071%
2/8/2024	ING Groep NV	40,000	$2.35M	0.0%	N/A	0.057%
2/8/2024	Quadrant Capital Group LLC	515	$30K	0.0%	+284.3%	0.001%
2/7/2024	Principal Financial Group Inc.	10,784	$0.63M	0.0%	-5.0%	0.015%
2/7/2024	Dimensional Fund Advisors LP	422,059	$24.80M	0.0%	-35.2%	0.602%
2/7/2024	BNP Paribas Financial Markets	55,977	$3.29M	0.0%	+2.1%	0.080%
2/7/2024	Teacher Retirement System of Texas	9,741	$0.57M	0.0%	-32.7%	0.014%
2/7/2024	Alpine Associates Management Inc.	1,881,400	$110.53M	5.7%	N/A	2.682%
2/7/2024	Kellner Capital LLC	41,400	$2.43M	4.4%	N/A	0.059%
2/7/2024	E Fund Management Co. Ltd.	8,503	$0.50M	0.0%	-33.7%	0.012%
2/6/2024	Charles Schwab Investment Management Inc.	365,428	$21.47M	0.0%	+6.4%	0.521%
2/6/2024	BCK Capital Management LP	16,000	$0.94M	0.9%	N/A	0.023%
2/6/2024	Maryland State Retirement & Pension System	4,254	$0.25M	0.0%	N/A	0.006%
2/6/2024	National Bank of Canada FI	473,500	$27.99M	0.0%	N/A	0.675%
2/6/2024	Amalgamated Bank	7,512	$0.44M	0.0%	+10.3%	0.011%
2/6/2024	Swiss National Bank	83,000	$4.88M	0.0%	-25.8%	0.118%
2/6/2024	Deuterium Capital Management LLC	15,000	$0.88M	2.8%	N/A	0.021%
2/6/2024	New York Life Investment Management LLC	255,584	$15.02M	0.2%	N/A	0.364%
2/5/2024	Victory Capital Management Inc.	7,466	$0.44M	0.0%	+5.7%	0.011%
2/2/2024	Headlands Technologies LLC	5,449	$0.32M	0.1%	+941.9%	0.008%
2/2/2024	Callan Capital LLC	6,431	$0.38M	0.0%	+18.4%	0.009%
2/2/2024	State of New Jersey Common Pension Fund D	44,027	$2.59M	0.0%	-34.7%	0.063%
2/2/2024	NJ State Employees Deferred Compensation Plan	4,500	$0.26M	0.0%	N/A	0.006%
2/1/2024	New York State Common Retirement Fund	40,200	$2.36M	0.0%	-87.3%	0.057%
2/1/2024	Handelsbanken Fonder AB	11,000	$0.65M	0.0%	-7.6%	0.016%
2/1/2024	Signaturefd LLC	1,021	$60K	0.0%	+76.9%	0.001%
1/31/2024	Greenleaf Trust	3,608	$0.21M	0.0%	N/A	0.005%
1/31/2024	Calamos Advisors LLC	277,808	$16.32M	0.1%	N/A	0.396%
1/31/2024	Federated Hermes Inc.	1,440	$85K	0.0%	N/A	0.002%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	10,666	$0.63M	0.0%	-6.1%	0.015%
1/30/2024	Mcdonald Capital Investors Inc. CA	4,250	$0.25M	0.0%	N/A	0.006%
1/29/2024	Simplicity Solutions LLC	3,135,973	$184.24M	5.0%	N/A	4.470%
1/24/2024	Arizona State Retirement System	11,764	$0.69M	0.0%	-18.8%	0.017%
1/24/2024	China Universal Asset Management Co. Ltd.	8,117	$0.48M	0.1%	+363.3%	0.012%
1/12/2024	SG Americas Securities LLC	32,408	$1.90M	0.0%	-34.6%	0.046%
1/11/2024	Handelsinvest Investeringsforvaltning	3,110	$0.18M	0.1%	N/A	0.004%
1/5/2024	Exchange Traded Concepts LLC	4,242	$0.25M	0.0%	+34.0%	0.006%
12/19/2023	Public Employees Retirement System of Ohio	18,591	$0.81M	0.0%	-10.0%	0.027%
12/18/2023	Vanguard Group Inc.	5,699,632	$248.28M	0.0%	+14.5%	8.125%
12/1/2023	Wellington Management Group LLP	3,319,922	$144.62M	0.0%	-2.0%	4.733%
11/30/2023	Neo Ivy Capital Management	24,720	$1.08M	0.5%	N/A	0.035%
11/24/2023	Deutsche Bank AG	242,561	$10.57M	0.0%	+3.0%	0.346%
11/15/2023	RTW Investments LP	6,768,514	$294.84M	6.2%	+51.3%	9.649%
11/15/2023	Rock Springs Capital Management LP	1,131,207	$49.28M	1.3%	+0.9%	1.613%
11/15/2023	Sectoral Asset Management Inc.	181,904	$7.92M	1.5%	+22.5%	0.259%
11/15/2023	Adage Capital Partners GP L.L.C.	1,175,000	$51.18M	0.1%	N/A	1.675%
11/15/2023	Armistice Capital LLC	1,364,098	$59.42M	0.9%	-65.7%	1.945%
11/15/2023	Affinity Asset Advisors LLC	60,426	$2.63M	0.7%	N/A	0.086%
11/14/2023	Schonfeld Strategic Advisors LLC	30,700	$1.34M	0.0%	-76.3%	0.044%
11/14/2023	Gotham Asset Management LLC	10,708	$0.47M	0.0%	N/A	0.015%
11/14/2023	Corton Capital Inc.	22,301	$0.97M	0.5%	+80.6%	0.032%
11/14/2023	Teza Capital Management LLC	6,590	$0.29M	0.0%	N/A	0.009%
11/14/2023	Profund Advisors LLC	41,039	$1.79M	0.1%	+5.7%	0.059%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	42,649	$1.86M	0.0%	-63.6%	0.061%
11/13/2023	Fishman Jay A Ltd. MI	5,000	$0.22M	0.0%	N/A	0.007%
11/13/2023	Algert Global LLC	74,286	$3.24M	0.2%	+1.0%	0.106%
11/13/2023	Acadian Asset Management LLC	883	$38K	0.0%	+77.7%	0.001%
11/13/2023	FMR LLC	1,527,828	$66.55M	0.0%	+1,134.3%	2.178%
11/13/2023	Envestnet Asset Management Inc.	82,413	$3.59M	0.0%	+267.2%	0.117%
11/13/2023	Rhenman & Partners Asset Management AB	175,000	$7.62M	0.8%	+25.0%	0.249%
11/13/2023	Rafferty Asset Management LLC	249,612	$10.87M	0.1%	+14.2%	0.356%
11/13/2023	Maven Securities LTD	90,000	$3.92M	0.0%	N/A	0.128%
11/13/2023	E Fund Management Co. Ltd.	12,823	$0.56M	0.0%	+9.0%	0.018%
11/9/2023	Rhumbline Advisers	51,871	$2.26M	0.0%	+0.8%	0.074%
11/9/2023	Fiera Capital Corp	1,038,836	$45.25M	0.1%	+50.1%	1.481%
11/9/2023	Deutsche Bank AG	242,561	$10.57M	0.0%	+3.0%	0.346%
11/9/2023	Skandinaviska Enskilda Banken AB publ	13,139	$0.57M	0.0%	-72.8%	0.019%
11/9/2023	Pier 88 Investment Partners LLC	16,440	$0.72M	0.2%	+108.4%	0.023%
11/8/2023	State of New Jersey Common Pension Fund D	67,396	$2.94M	0.0%	N/A	0.115%
11/8/2023	Campbell & CO Investment Adviser LLC	31,587	$1.38M	0.2%	N/A	0.054%
11/8/2023	Charles Schwab Investment Management Inc.	343,442	$14.96M	0.0%	-21.2%	0.586%
11/8/2023	Swiss National Bank	111,800	$4.87M	0.0%	+26.2%	0.191%
11/8/2023	Oppenheimer Asset Management Inc.	10,507	$0.46M	0.0%	+28.0%	0.018%
11/7/2023	Virtus ETF Advisers LLC	2,684	$0.12M	0.1%	-9.1%	0.005%
11/7/2023	Alpha DNA Investment Management LLC	14,423	$0.63M	0.3%	N/A	0.025%
11/7/2023	New York State Common Retirement Fund	317,601	$13.84M	0.0%	+36.4%	0.542%
11/7/2023	Barclays PLC	127,774	$5.57M	0.0%	+23.0%	0.218%
11/7/2023	Jump Financial LLC	40,667	$1.77M	0.1%	N/A	0.069%

Data available starting January 2016

Mirati Therapeutics, Inc., a commercial-stage oncology company, develops novel therapeutics to address the genetic and immunological promoters of cancer in the United States. The company provides KRAZATI, an oral targeted treatment option for adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung (NSCLC), as well as in clinical development as a monotherapy and in combination with other agents. It also develops Sitravatinib, an investigational spectrum-selective kinase inhibitor in Phase 3 clinical development that inhibits receptor tyrosine kinases (RTKs), including TAM family receptors, split family receptors, and RET, which overcomes resistance to checkpoint inhibitor therapy through targeted reversal of an immunosuppressive tumor microenvironment that enhances antigen-specific T cell response and expanding dendritic cell-dependent antigen presentation. In addition, the company pipeline comprises the MRTX1719, an investigational synthetic lethal PRMT5 inhibitor designed to target the PRMT5/methylthioadensoine (MTA) complex and is in clinical development; MRTX0902, a selective SOS1 inhibitor that improves anti-tumor efficacy in combination with targeted mitogen-activated protein kinase (MAPK)-pathway inhibitors, and is in clinical development; and MRTX1133, an investigational lead KRAS G12D compound. It has a collaboration and license agreement with BeiGene, Ltd. to develop, manufacture, and commercialize sitravatinib; and Zai Lab Ltd. to research, develop, manufacture, and commercialize adagrasib in various indications. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.

Today's Range

Now: $58.70

$58.70

50 Day Range

MA: $58.82

$58.70

$59.28

52 Week Range

Now: $58.70

$27.30

$64.41

Volume

N/A

Average Volume

2,758,857 shs

Market Capitalization

$4.12 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.77

Who are the company insiders with the largest holdings of Mirati Therapeutics?: Mirati Therapeutics' top insider shareholders include:
Boxer Capital, Llc (Insider)
Charles M Baum (Insider)
Jamie Christensen (EVP)
Benjamin Hickey (EVP)
Laurie Stelzer (CFO)
David D Meek (CEO)
Faheem Hasnain (Director)
Julie M Cherrington (Director)
Learn More about top insider investors at Mirati Therapeutics.